Welcome to our dedicated page for Philip Morris International news (Ticker: PM), a resource for investors and traders seeking the latest updates and insights on Philip Morris International stock.
Philip Morris International Inc. (PM) is a leading American multinational tobacco company that has built a global presence with its products being sold in over 180 countries. Known for its flagship product, Marlboro, Philip Morris International is a major player in the tobacco industry, often referred to as part of 'Big Tobacco'.
The company's portfolio is extensive, primarily consisting of traditional cigarettes but also embracing reduced-risk products. These include heat-not-burn devices, vapor products, and oral nicotine products, which are marketed in regions outside the United States. Recent strategic moves highlight their shift towards diversification. In 2022, Philip Morris International acquired Swedish Match, a prominent manufacturer of traditional oral tobacco products and nicotine pouches, boosting their presence in the US and Scandinavian markets.
In a bid to expand beyond nicotine-based products, Philip Morris International acquired Vectura in 2021. Vectura specializes in innovative inhaled drug delivery solutions, marking the company's foray into the healthcare sector.
Financially, Philip Morris International has demonstrated resilience and adaptability, managing to sustain growth through an evolving product lineup and strategic acquisitions. With a strong focus on innovation and a commitment to reducing the harmful effects of tobacco, the company is well-positioned to navigate the challenges of an industry in transition.
Philip Morris International's latest news can be found on their official website, providing current updates on their financial performance, new product launches, partnerships, and other significant developments.
Philip Morris International (PM) announced a leadership succession plan set to be finalized in May 2021. André Calantzopoulos will transition from CEO to Executive Chairman, while Jacek Olczak will become the new CEO. This change follows Mr. Louis Camilleri's retirement as Chairman. The transition aims for continuity in leadership, highlighting the company’s strategic vision and achievements in smoke-free product development. Olczak, with extensive experience in the company, is expected to drive future innovation and shareholder value.
The Board of Directors of Philip Morris International (NYSE: PM) has declared a quarterly dividend of $1.20 per common share, payable on January 11, 2021, to shareholders on record as of December 23, 2020. The ex-dividend date is December 22, 2020. PMI is committed to transforming the tobacco industry towards a smoke-free future, aiming to replace traditional cigarettes with innovative smoke-free products, such as the IQOS device, which has attracted over 11.7 million adult smokers globally.
Philip Morris International (PM) has received commendations from CDP and Science Based Targets initiative (SBTi) for its sustainability initiatives. PMI is among only 10 companies globally to achieve a 'Triple A' from CDP over its climate change and water security efforts. Furthermore, SBTi has verified PMI's emissions targets, aligning them with the Paris Agreement goals. CEO André Calantzopoulos emphasized their commitment to sustainability, aiming for carbon neutrality in direct operations by 2030 and across the value chain by 2050. PMI's dedication to reducing environmental impact is highlighted through various strategic programs.
The FDA has authorized the sale of Philip Morris International's IQOS 3, an advanced electrically heated tobacco system, citing it as beneficial for public health. This decision follows a premarket tobacco product application submitted in March 2020. IQOS 3 features improved battery life and faster recharge times. The FDA reported no increased usage among youth and young adults. PMI's CEO stated that this approval could accelerate the transition from smoking to less harmful alternatives. The authorization is in line with previous PMTA orders aimed at minimizing unintended use among youth.
Philip Morris International (PMI) has joined The Valuable 500, a global initiative aimed at improving disability inclusion in business. CEO André Calantzopoulos emphasized that this commitment will not only enhance workplace diversity but also help the company tap into the talent of individuals with disabilities. PMI plans to establish a Global Employee Resource Group on Disability, improve accessibility in communication technologies, and address stigma around disability and mental health. This strategic move aligns with PMI's vision for a smoke-free future.
Philip Morris International Inc. (NYSE:PM) CFO Emmanuel Babeau addressed investors at the Morgan Stanley Virtual Global Consumer & Retail Conference. He revised the full-year 2020 reported diluted EPS forecast to approximately $5.08, slightly up from the previous range of $5.03 to $5.08. This revision reflects lower costs due to efficiencies and pandemic-related adjustments. The forecast suggests a 6% increase from the pro forma adjusted diluted EPS of $5.13 in 2019. Key assumptions include HTU shipment volumes of 75 to 76 billion units and market share gains in IQOS geographies.
Philip Morris International (PM) will hold a live video webcast featuring CFO Emmanuel Babeau at the Morgan Stanley Virtual Global Consumer & Retail Conference on December 2, 2020, starting at 10:00 a.m. ET. The session will be accessible via www.pmi.com/2020morganstanley, where presentation slides will also be available. An archived version of the webcast will remain online until December 31, 2020. PMI is committed to transitioning to a smoke-free future, with around 11.7 million adult smokers switching to its heat-not-burn product as of September 30, 2020.
Philip Morris Investments B.V., a subsidiary of Philip Morris International (PM), holds a one-third stake in Medicago, focusing on plant-derived vaccine development. Medicago has secured a deal with the Canadian government to supply 76 million doses of its COVID-19 vaccine, with C$173M ($131M) funding for its trials and manufacturing. PMI's CEO praised the collaboration to accelerate vaccine development. Medicago is currently advancing through clinical trials, with Phase 1 testing completed on July 14, and anticipates Phase 2 trials to start in November 2020.
Philip Morris International Inc. (NYSE:PM) reported its 2020 third-quarter results, highlighting a reported diluted EPS of $1.48, up 21.3%. Adjusted diluted EPS decreased by 0.7% to $1.42, while organic growth showed a 5.6% increase. Cigarette and heated tobacco volume shipments fell by 7.6%, but IQOS market share rose to 6.0%. Net revenues declined 2.6%, and operating income increased by 16.3%. The company raised its full-year diluted EPS guidance to $5.03-$5.08, driven by improved industry volumes and favorable tax effects. PMI assured no significant supply disruptions amid COVID-19.
FAQ
What is the current stock price of Philip Morris International (PM)?
What is the market cap of Philip Morris International (PM)?
What is Philip Morris International Inc. known for?
In how many countries are Philip Morris International's products sold?
What are some of the reduced-risk products offered by Philip Morris International?
What strategic acquisitions has Philip Morris International made recently?
What is Swedish Match known for?
What does Vectura specialize in?
How does Philip Morris International plan to reduce the harmful effects of tobacco?
Where can I find the latest news about Philip Morris International?
What is the financial condition of Philip Morris International?
Why is Philip Morris International considered part of 'Big Tobacco'?
